AVITA Medical: Reimbursement Reset And Breakeven Path By 2026
AVITA MedicalAVITA Medical(US:RCEL) Seeking Alpha·2025-09-18 11:30

Company Overview - AVITA Medical, Inc. (NASDAQ: RCEL) specializes in full-thickness wound reconstruction with a comprehensive product portfolio [1] - The company offers RECELL and RECELL GO for point-of-care autologous "Spray-On Skin" applications [1] - Additional products include Cohealyx for graft-ready dermis and PermeaDerm as a protective biosynthetic cover, developed in partnership [1]